Invesco Ltd: Form 8.3 - Quanex Building Products Corporation
June 14, 2024 08:33 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
June 14, 2024 08:29 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
Invesco Ltd: Form 8.3 - DS Smith PLC
June 14, 2024 08:29 ET
|
Invesco Ltd.
FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)Full name of...
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
June 14, 2024 08:00 ET
|
Oryzon Genomics, S.A.
Data from the first two cohorts demonstrated that combination of iadademstat plus gilteritinib was safe and showed strong antileukemic activityA third cohort is ongoing following FDA’s OPTIMUS...
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
June 14, 2024 07:14 ET
|
Hymson
Shenzhen , June 14, 2024 (GLOBE NEWSWIRE) -- As an expert in the laser industry, Hymson has dedicated 16 years to laser application. It has accumulated profound expertise in product development and...
Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health
June 14, 2024 07:00 ET
|
Tilray Brands, Inc.
With this campaign and the partnerships involved, Tilray hopes to encourage more men to take an active role in their health and well-being.
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
June 14, 2024 07:00 ET
|
Autolus Therapeutics plc
Autolus Therapeutics to Present Three Clinical Data Updates on obe-cel at EHA
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE SILVER 3X DAILY SHORT SECURITIES ISIN: IE00B8JG1787 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTE
June 14, 2024 06:47 ET
|
WisdomTree Multi Asset Issuer PLC
14 June 2024 LEI: 2138003QW2ZAYZODBU23 LSE Code: 3SIS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE SILVER 3X DAILY...
Form 8.5 (EPT/RI) - Touchstone Exploration Inc
June 14, 2024 06:21 ET
|
Shore Capital Stockbrokers Limited
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) ...
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
June 14, 2024 06:16 ET
|
Dimensional Fund Advisors Ltd
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...